Category Archives: Spinal Cord Injury Treatment

When we think of physical therapy, we usually imagine exercise, stretching, massage, and rehabilitation sessions. And that would all be true. Nevertheless, this field of restorative health is far greater than we can fathom Continue reading →

Global Catheters Market: Snapshot Catheters are medical tubes that are inserted in the body cavities, vessels, or ducts to remove fluids, perform a surgery, or treat diseases. Whereas, catheters are mostly used for removing fluids by inserting in body cavities, particularly the bladder. These flexible tubes play a very significant role for aged people and patients with medical conditions that impairs the ability to urinate. Continue reading →

Four in 10 British adults are in chronic pain, meaning they are experiencing discomfort for more than three months at a time. Bad backs, headaches and cramps are often to blame, and for one in 10, they are in so much pain it is severely disabling. Continue reading →

Market Summary Follow InVivo Therapeutics Holdings Corp. is a InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury Continue reading →

Construction has begun in northeast Bakersfield on a two-story, 50-bed inpatient rehabilitation hospital whose developers see it becoming part of a 46-acre medical-oriented complex along Highway 178 at Morning Drive. Vibra Healthcare Rehabilitation Hospital, announced Monday, is expected to offer advanced medical treatment for patients suffering from stroke, amputation, spinal cord injury, burns and arthritis, among many other conditions. The 60,000-square-foot building will join health-care facilities already operating at Rio Bravo Medical Campus, which is planned to later include 16 acres of neighborhood retail space and 17 acres of medium-density housing Continue reading →

Synchron's Stentrode brain-computer interface system is a fully-implantable therapeutic US based Synchron Inc., a neurovascular bioelectronic medicine company, has announced that theUniversity of Melbournehas been awarded an AUD$1.5MMedical Research Future Fundgrant from the National Health and Medical Research Council (NHMRC) of the Australian Government to expand the current clinical study ofSynchron's Stentrode. The study is the first clinical trial to evaluate the safety and efficacy of the Stentrode, the first interventional neuromodulation platform. Continue reading →

Share Share Share Email Alan Sau/Shutterstock . It seems like every day experts have new opinions on how the economy is being affected by COVID-19. Continue reading →

Photography by David Sparks Jump to story A closer look at heart defects Elevating stroke recovery Peering into proteins Robots in the operating room Beating breast cancer 3D printing is changing congenital heart disease. By Megan Sarnacki Every year, approximately 40,000 babies are born with a congenital heart defect in the United States, according to the Centers for Disease Control and Prevention Continue reading →

Researchers at Temple University have made a discovery that raises hope of restored functions for people with spinal cord injuries and other related issues. In a study published in Molecular Therapy, researchers said they were able to regenerate neurons in mice that had spinal cord injury and optic nerve damage. They succeeded in restoring lost functions in the animals with the aid of a molecule called Lin28. Continue reading →

CARLSBAD, Calif.--(BUSINESS WIRE)-- Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced that updated results from a Phase I/IIa study of its lead product candidate, OpRegen, a retinal pigment epithelium (RPE) cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (AMD), were published online via the ARVOLearn platform as part of the 2020 Association for Research in Vision and Ophthalmology (ARVO) Meeting. Continue reading →